Published in BMC Res Notes on April 29, 2016
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2009) 35.34
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol (2006) 6.57
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg (2010) 2.81
Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol (2013) 2.80
Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg (2003) 2.80
Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab (2004) 2.71
Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer (2003) 2.58
Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer (1998) 2.57
Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) (2014) 2.56
Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab (2006) 2.31
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery (2008) 2.23
Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease. J Postgrad Med (2007) 2.20
The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations. J Clin Endocrinol Metab (2013) 2.17
Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries. J Clin Endocrinol Metab (2013) 1.86
Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases. Ann Surg (2011) 1.64
Differentiated thyroid cancers 11-20 mm in diameter have clinical and histopathologic characteristics suggesting higher aggressiveness than those < or =10 mm. Thyroid (2008) 1.47
Management of low-risk differentiated thyroid cancer. Endocr Pract (2007) 1.39
Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid (2007) 1.27
The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries. Thyroid (2015) 1.16
Recent outcome of Graves' disease patients with papillary thyroid cancer. Eur J Endocrinol (2007) 1.14
Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg (1996) 1.13
Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. J Clin Endocrinol Metab (1992) 1.11
Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up. J Clin Endocrinol Metab (2014) 1.00
Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma. Eur J Endocrinol (2012) 0.97
Incidence and histopathological behavior of papillary microcarcinomas: study of 429 cases. Otolaryngol Head Neck Surg (2008) 0.96
Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid (2005) 0.95
Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol (2006) 0.94
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases. Thyroid (2013) 0.93
Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer (2008) 0.88
Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid (2013) 0.87
Incidental thyroid carcinoma in patients with Graves' disease. Am J Surg (2008) 0.86
Occult thyroid carcinoma in a Greek population. Neoplasma (1987) 0.84
Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006. Anticancer Res (2009) 0.83
Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab (2012) 0.82
Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in Finnish thyroid cancer patients. Scand J Surg (2012) 0.82
Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: the majority are incidental. Thyroid (2009) 0.82
Thyroid cancer associated with adenomatous goiter: an analysis of the incidence and clinical factors. Surg Today (1997) 0.81
Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece. Clin Endocrinol (Oxf) (1999) 0.81
Thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab (2012) 0.79
Management of papillary thyroid microcarcinoma: primum non nocere! J Clin Endocrinol Metab (2013) 0.77